Biotech
Vima Therapeutics
Vima Therapeutics raises $60M Series A at $280M valuation
$60M
Total Raised
Series A
Latest Round
2023
Founded
50+
Employees
Cambridge, MA
1 min read
Quick Facts
Valuation
$280M
Latest Round Size
$60M
Latest Round Date
May 2024
Vima Therapeutics: Series A Funding Round
Vima Therapeutics has successfully raised $60M in Series A funding, reaching a valuation of $280M.
Company Overview
Focused on oral therapies for movement disorders
Funding Details
The Series A round was led by Third Rock Ventures, with participation from Arch Venture Partners.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2023
- Employees: 50+
- Category: Biotech
Investment
Vima Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Third Rock Ventures: Verified investor in Series A
- Arch Venture Partners: Verified investor in Series A
Key Investors
Third Rock Ventures
Lead Investor
Verified investor in Series A
Arch Venture Partners
Investor
Verified investor in Series A
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M